171 related articles for article (PubMed ID: 34632486)
1. Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
Eur J Cardiothorac Surg; 2022 Jan; 61(2):249-256. PubMed ID: 34632486
[TBL] [Abstract][Full Text] [Related]
2. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
Zhong Y; Xu Y; Deng J; Wang T; Sun X; Chen D; Wu C; Hou L; Xie H; She Y; Xie D; Chen C
Eur J Cardiothorac Surg; 2021 Apr; 59(3):624-632. PubMed ID: 33188689
[TBL] [Abstract][Full Text] [Related]
4. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
[TBL] [Abstract][Full Text] [Related]
5. Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity.
Li M; Xi J; Zhang H; Jin X; Zhang J; Feng M; Zhan C; Wang Q
Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):320-328. PubMed ID: 35644565
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component.
Hattori A; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2020 Feb; 109(2):420-427. PubMed ID: 31593656
[TBL] [Abstract][Full Text] [Related]
7. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
Eur J Cardiothorac Surg; 2022 Mar; 61(4):769-777. PubMed ID: 34791156
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
[TBL] [Abstract][Full Text] [Related]
10. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.
Berry MF; Gao R; Kunder CA; Backhus L; Khuong A; Kadoch M; Leung A; Shrager J
Clin Lung Cancer; 2018 Jan; 19(1):e47-e51. PubMed ID: 28743420
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580
[TBL] [Abstract][Full Text] [Related]
12. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
13. The role of the ground-glass opacity ratio in resected lung adenocarcinoma.
Huang TW; Lin KH; Huang HK; Chen YI; Ko KH; Chang CK; Hsu HH; Chang H; Lee SC
Eur J Cardiothorac Surg; 2018 Aug; 54(2):229-234. PubMed ID: 29471517
[TBL] [Abstract][Full Text] [Related]
14. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
[TBL] [Abstract][Full Text] [Related]
15. Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT.
Park S; Lee SM; Choe J; Choi S; Do KH; Seo JB
Radiology; 2023 May; 307(3):e222422. PubMed ID: 36943079
[TBL] [Abstract][Full Text] [Related]
16. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.
Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J
Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267
[TBL] [Abstract][Full Text] [Related]
17. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
18. Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance.
Hattori A; Matsunaga T; Fukui M; Tomita H; Takamochi K; Suzuki K
J Thorac Cardiovasc Surg; 2023 Nov; ():. PubMed ID: 37995863
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung Cancer.
Hattori A; Matsunaga T; Fukui M; Suzuki K; Takamochi K; Suzuki K
Semin Thorac Cardiovasc Surg; 2022 Sep; ():. PubMed ID: 36180013
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Patient and Lesion Features Are Valuable for Predicting the Prognosis of Resectable Peripheral Non-Small Cell Lung Cancer.
Qi LP; Li XT; Ma ZM; Yang Y; Chen JF; Sun YS
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):584-592. PubMed ID: 35405686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
